Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2007-11-26
pubmed:abstractText
We have shown that the bacterial iron chelator, deferoxamine (DFO), triggers inflammatory signals including the production of CXC chemokine IL-8, in human intestinal epithelial cells (IECs) by activating the ERK1/2 and p38 kinase pathways. In this study we investigated the mechanisms involved in IL-8 generation by DFO, focusing on the transcription factors involved and the roles of both mitogen-activated protein kinases (MAPKs) in the transcription factor activation. Treatment of human epithelial HT-29 cells with DFO markedly up-regulated the expression of the essential components of the transcription factor AP-1 at a transcriptional level, while it minimally affected the expression of the NF-kappaB subunits. DFO also induced AP-1-dependent transcriptional activity in HT-29 cells, and this activity was further augmented by the wild-type c-Jun transfection. In contrast, the AP-1 activity by DFO was markedly decreased by the dominant-negative c-Jun transfection. Electrophoretic mobility shift assays revealed that DFO increases the specific binding of AP-1 but not of NF-kappaB. Such AP-1 binding and transcriptional activities were blocked by the inhibitors of the ERK1/2 and p38 kinase pathways, suggesting that both mitogen-activated protein kinases (MAPKs) lie upstream of AP-1. Besides its action on AP-1, DFO also induced the specific binding of other transcription factors such as CREB and Egr-1. In summary, our results indicate that iron chelator-induced IL-8 generation in IECs involves activation of ERK1/2 and p38 kinase and downstream activation of AP-1. A possible link between iron status and two additional transcription factors, that is, CREB and Egr-1, rather than NF-kappaB, was also suggested.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0730-2312
pubmed:author
pubmed:copyrightInfo
Copyright (c) 2007 Wiley-Liss, Inc.
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
102
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1442-57
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:17471497-Cell Survival, pubmed-meshheading:17471497-Colon, pubmed-meshheading:17471497-Deferoxamine, pubmed-meshheading:17471497-Electrophoretic Mobility Shift Assay, pubmed-meshheading:17471497-Enzyme Activation, pubmed-meshheading:17471497-Epithelial Cells, pubmed-meshheading:17471497-Extracellular Signal-Regulated MAP Kinases, pubmed-meshheading:17471497-Formazans, pubmed-meshheading:17471497-HT29 Cells, pubmed-meshheading:17471497-Humans, pubmed-meshheading:17471497-Interleukin-8, pubmed-meshheading:17471497-Iron Chelating Agents, pubmed-meshheading:17471497-Luciferases, pubmed-meshheading:17471497-Models, Biological, pubmed-meshheading:17471497-NF-kappa B, pubmed-meshheading:17471497-Tetrazolium Salts, pubmed-meshheading:17471497-Transcription, Genetic, pubmed-meshheading:17471497-Transcription Factor AP-1, pubmed-meshheading:17471497-p38 Mitogen-Activated Protein Kinases
pubmed:year
2007
pubmed:articleTitle
Transcriptional regulation of IL-8 by iron chelator in human epithelial cells is independent from NF-kappaB but involves ERK1/2- and p38 kinase-dependent activation of AP-1.
pubmed:affiliation
Department of Life Science, Gwangju Institute of Science and Technology (GIST), Gwangju, Korea.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't